Fidaxomicin
Criteria for Use

Criteria for Use

May only be ordered for patients who have documented TOXIN-POSITIVE Clostridium difficile infection (CDI) and at least one of the following:

  • First or greater CDI recurrence within 1-year
  • Severe CDI (WBC >15 or SCr >1.5)
  • Therapeutic failure of oral vancomycin +\- metronidazole (defined as persistent or refractory infection while on treatment for CDI)
  • Age ≥ 65
  • Concomitant antibiotics
  • Immunocompromised